Status:
COMPLETED
Safety and Efficacy of Non-ablative Er:YAG Laser Therapy for the Treatment of Pelvic Organ Prolapse and Coexisting Stress Urinary Incontinence: A Retrospective Case Series.
Lead Sponsor:
Aleksandra Novakov Mikic
Conditions:
Cystocele
Pelvic Organ Prolapse
Eligibility:
FEMALE
18+ years
Brief Summary
The objective of the study is to retrospectively collect the data on patients who underwent pelvic organ prolapse treatment using a non-ablative Er:YAG laser with SMOOTH mode and to conduct an objecti...
Detailed Description
Pelvic organ prolapse (POP) and stress urinary incontinence (SUI) affect many women and can dramatically decrease their quality of life. Most of the patients diagnosed with stress urinary incontinence...
Eligibility Criteria
Inclusion
- All patients that had pelvic organ prolapse with or without concomitant stress urinary incontinence and that were treated using non-ablative Fotona Er:YAG laser (ProlapLase treatment) in the time period from 2015 to 2016 will be included in this retrospective study.
Exclusion
- Patients who failed to attend a follow-up appointment will be excluded from this retrospective case series study.
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04417413
Start Date
October 1 2019
End Date
December 31 2019
Last Update
November 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poliklinika Novakov i sar.
Novi Sad, Serbia, 21000